Inhibition of glycolysis alleviates lipopolysaccharide‐induced acute lung injury in a mouse model

Wen‐Jing Zhong,Hui‐Hui Yang,Xin‐Xin Guan,Jian‐Bing Xiong,Chen‐Chen Sun,Chen‐Yu Zhang,Xiao‐Qin Luo,Yan‐Feng Zhang,Jun Zhang,Jia‐Xi Duan,Yong Zhou,Cha‐Xiang Guan

DOI: https://doi.org/10.1002/jcp.27261

2018-09-07

Journal of Cellular Physiology

Abstract:Gluconic metabolic reprogramming, immune response, and inflammation are intimately linked. Glycolysis involves in the pathologic progress in acute and chronic inflammatory diseases. However, the involvement of glycolysis in the acute lung injury (ALI) is still unclear. This study investigated the role of glycolysis in an animal model of ALI. First, we found that lactate content in serum was remarkably increased in ALI patients and a murine model induced by intratracheal administration of lipopolysaccharide (LPS). The key proteins involving in glycolysis were robustly elevated, including HK2, PKM2, and HIF-1α. Intriguingly, inhibition of glycolysis by 2-deoxyglucose (2-DG) pronouncedly attenuated the lung tissue pathological injury, accumulation of neutrophil, oxidative stress, expression of proinflammatory factors in the lung of ALI mice induced by LPS. The 2-DG treatment also strongly suppressed the activation of the NOD-like receptor (NLR) family and pyrin domain-containing protein 3 (NLRP3) inflammasome. Furthermore, we investigated the role of glycolysis in the inflammatory response of primary murine macrophages activated by LPS in vitro. We found that the 2-DG treatment remarkably reduced the expression of proinflammatory factors induced by LPS, including tumor necrosis factor-α messenger RNA (mRNA), pro-interleukin (IL)-1β mRNA, pro-IL-18 mRNA, NLRP3 mRNA, caspase-1 mRNA, and IL-1β protein. Altogether, these data provide a novel link between gluconic metabolism reprogramming and uncontrolled inflammatory response in ALI. This study suggests glycolytic inhibition as an effective anti-inflammatory strategy in treating ALI.

cell biology,physiology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of glycolysis in lipopolysaccharide (LPS) - induced acute lung injury (ALI) in mice and to evaluate whether inhibiting glycolysis can relieve the symptoms of ALI. Specifically, the researchers focused on the following aspects:

1. **Occurrence of glycolysis in ALI**: By detecting the changes in lactate levels and related gene expressions in ALI patients and LPS - induced ALI mouse models, determine whether glycolysis is activated during the ALI process.
2. **Effect of inhibiting glycolysis on ALI**: Use 2 - deoxy - D - glucose (2 - DG) as a glycolysis inhibitor and observe its effects on the pathological damage, inflammatory cell accumulation, oxidative stress and pro - inflammatory factor expression in LPS - induced ALI mice.
3. **Relationship between glycolysis and NLRP3 inflammasome**: Explore whether glycolysis inhibition can alleviate ALI by regulating the activation of NLRP3 inflammasome.

### Main findings

1. **Glycolysis is significantly enhanced in ALI**: The serum lactate level in ALI patients is significantly increased, and a similar phenomenon is also observed in the LPS - induced ALI mouse model. In addition, the expressions of glycolysis - related genes (such as HK2, PKM2 and HIF - 1α) in the lung tissues of ALI mice are significantly increased.

\[
\text{Lactate concentration}=\text{Marker of glycolysis activity}
\]

2. **2 - DG pretreatment can alleviate LPS - induced ALI**:
- Decrease the lactate content in BALF and reduce the release of LDH in serum, indicating reduced cell damage.
- Significantly improve the pathological damage of lung tissues and reduce the infiltration of inflammatory cells, especially the accumulation of neutrophils.
- Reduce the total protein content in lung tissues and BALF, indicating improved lung vascular permeability.

3. **Inhibiting glycolysis alleviates oxidative stress**: 2 - DG pretreatment significantly reduces the content of MDA (lipid peroxidation product) while increasing the activity of SOD (antioxidant enzyme).

4. **Inhibiting glycolysis reduces the expression of pro - inflammatory factors**: 2 - DG pretreatment significantly reduces the mRNA and protein expressions of TNF - α, MCP - 1 and TREM - 1 and inhibits the degradation of IκBα.

5. **Inhibiting glycolysis inhibits the activation of NLRP3 inflammasome**: 2 - DG pretreatment significantly reduces the NLRP3 mRNA and its protein expression, decreases the expressions of pro - caspase - 1, ASC, pro - IL - 1β and pro - IL - 18, and finally reduces the production of IL - 1β.

### Conclusion

This study shows that glycolysis plays an important role in the occurrence and development of ALI, and inhibiting glycolysis can be used as an effective anti - inflammatory strategy for the treatment of ALI and other inflammatory diseases. This finding provides a theoretical basis for the development of new ALI treatment methods.